As of 2025-12-25, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (49.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -9131.9%.
The range of the Relative Valuation is (47.73) - (51.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 20.3x | 19.2x |
| Forward P/E multiples | 18.8x - 24.6x | 19.9x |
| Fair Price | (47.73) - (51.65) | (49.68) |
| Upside | -8778.1% - -9490.4% | -9131.9% |
| Date | P/E |